Illumina CEO Francis deSouza resigns
Georgejason/iStock Editorial via Getty Images

Chief Executive of Illumina (NASDAQ:ILMN) Francis deSouza has resigned from his position, the gene sequencing company announced on Sunday.
deSouza, who recently survived an activist campaign led by billionaire investor Carl Icahn will serve Illumina (ILMN) in an advisory capacity until July 31, the company added.

His resignation from the CEO position and board membership will take effect on July 11.
The company's board will conduct an executive search to find his replacement, while general counsel Charles Dadswell will function as interim CEO.

deSouza's departure comes days after Icahn lost his activist campaign against San Diego, California-based Illumina (ILMN), in which he strongly called for CEO's removal, citing the company's decision to acquire cancer test developer Grail despite regulatory pushback.
At the company's annual meeting in late May, Illumina (ILMN) shareholders voted to oust Chairman John Thompson and elect one of three Icahn nominees.


More on Illuminaâs proxy battle

Illumina names Hologic CEO as chair, elects Edwards CFO to board
Carl Icahn seeks to bring Illuminaâs former CEO back â WSJ
Icahn Reacts Audaciously To Illumina's Audacity